Literature DB >> 16732189

No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.

Bernard Descoeudres, Olivier Giannini, Tanja Graf, Jürg Steiger, Michael Mayr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732189     DOI： 10.1097/01.tp.0000203322.99037.d2

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  De novo and recurrent Kaposi's Sarcoma after renal transplantation in two patients taking everolimus.

Authors:  G Vergoulas; Gr Miserlis; M Leontsini; V Papanikolaou; D Takoudas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

2.  Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  Debasmita Roy; Dirk P Dittmer
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

3.  Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.

Authors:  Risa Chaisuparat; Jiadi Hu; Bruno C Jham; Zachary A Knight; Kevan M Shokat; Silvia Montaner
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.